Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT00831597 · COMPLETED
Trial details
- NCT number
- NCT00831597
- Sponsor
- Pharmatech
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.